In this pathway, GSH contributes to ascorbate regeneration by reducing DHA, either chemically or via enzymes called DHA reductases, which constitute a class of GSTs (Dixon et al., 2002)
Per-injection doses are larger (usually 2 to 5 milligrams) but the total weekly peptide load is roughly comparable to BPC-157 by cost
Rates of nausea were notably higher than with tirzepatide alone, which is consistent with the additive effect on gastric motility
Primary peptides: KPV at 300 to 500 mcg subcutaneously daily (mast cell stabilization) BPC-157 at 250 mcg subcutaneously twice daily (tissue repair, additional mast cell stabilization) Support peptide: Ta1 at 1.6 mg subcutaneously twice weekly (immune regulation) Implementation schedule: Week 1: Start KPV alone at lower dose (200 mcg) to assess tolerance Week 2: Add BPC-157 at 200 mcg twice daily
These combined effects create a multi-vector approach to skin remodeling that few other peptides can replicate
These are worth monitoring for future developments, though lyophilized reconstitution remains the standard for compounded formulations today
